Current Protocols
Full transparency. 8 active peptides, 29 supplements, every dose, route, schedule, and genetic reason. Cycling and discontinued protocols documented below.
These protocols are prescribed and supervised by licensed physicians. Doses are calibrated to my specific genetics, bloodwork, and medical history. Do not copy this protocol. Use it to inform conversations with your own doctor.
Some compounds listed are prescribed off-label or through compounding pharmacies. All sourced from a DEA-certified 503A/503B pharmacy under physician supervision.
My Protocol on Loop
This entire stack is managed on Loop Health. View the live protocol with pricing, or browse the peptide library.
Sourcing
DEA-registered, GMP-certified facilityLoop Bio Labs — 503A & 503B Compounding Pharmacy. 99%+ purity, COA with every order.
Active Peptides (8)
| Peptide | Dose | Route | Schedule | Note |
|---|---|---|---|---|
| NAD+ | ~120mg actual (200mg stated) | IM | Daily AM | Biofermented. Reconciled 2026-05-17 against order volume. |
| Methylcobalamin B12 | varies | SubQ | Daily AM | 10mL vial/month. Functional status TBD via MMA + Hcy due to TCN2 CG transport variant. |
| Semax | 10 units (double Loop dose) | Intranasal | M-F AM | BDNF, cognitive. |
| MOTS-c | ~10mg/week (full vial over 7 days) | SubQ | ~Daily | Mitochondrial, AMPK activation. |
| Kisspeptin-10 | 200mcg | SubQ | M/W/F AM | Started 2026-04-30. Fertility-preserving T optimization. Week 4 of trial. |
| CJC-1295 / Ipamorelin | Standard | SubQ | Bedtime | GH pulse at sleep onset. |
| Retatrutide | Weekly | SubQ | Weekly | GLP-1 / GIP / glucagon triple agonist. |
| GHK-Cu (topical) | Topical | Derma stamp | Daily | Hair protocol in Novamane base. Topical continues during systemic washout. |
Cycling Off (2)
~16 months continuous; no human safety data past ~12 weeks. Cycle decision after long run.
~5 months continuous nightly 20u. Clearing copper load, reassess. Topical continues.
Discontinued, Reserve, and Planned (9)
Permanently discontinued. — Mast cell degranulation reaction (April 2026); Feb eosinophils 6.1% confirmed the dx — now resolved at 4.0% (May 28 labs).
Discontinued after ~1 week trial. — Hunger spike was unmanageable. Replaced with CJC-1295/Ipamorelin nightly.
Held in reserve. — Backup if kisspeptin response inadequate at week 8 (~2026-06-25). Not stacked initially.
Off the table during TTC. — Would shut down FSH. Fertility-preserving protocols only.
Paused.
Given to partner.
Last cycle Feb 2026. Repeat every 4-6 months.
Cycle complete, on break.
Planned after nutrition dialed.
Supplement Stack (29)
| Supplement | Dose | Timing | Why |
|---|---|---|---|
| NMN↗ | 1000mg (reducing to 600mg per 2024 RCTs) | AM | NAD+ precursor |
| NAC↗ | 1800mg total (split AM/PM) | AM/PM | GCLM AG — ~20-30% reduced glutathione synthesis |
| Glycine | 10g/day (5g AM + 5g PM) | AM/PM | GlyNAC — added 2026-03-21 |
| Glutathione↗ | 500mg | AM | GCLM AG — reduced GSH synthesis |
| B-Complex (Neuro 110) | 1 capsule | AM | MTHFR compound het |
| Methylfolate | 15mg | AM | 9-variant methylation defect (MTHFR het ×2 + FUT2 AA + MTRR AA + MTR AG + TCN2 CG + BHMT AG + RFC1 CC) |
| P5P (B6) | 50mg | AM | Methylation cofactor |
| Betaine (TMG) | Standard | AM | BHMT AG |
| Green Tea Phytosome | 250mg | AM | EGCG |
| Avmacol (Sulforaphane)↗ | Glucoraphanin 480mg | AM | NRF2 activator |
| Nitric Oxide Booster | L-Arg 500mg + AKG 500mg + Cit 375mg (3 pills) | AM | Circulation |
| Tongkat Ali↗ | 400mg | AM | T support |
| Vitamin A (retinol) | 10,000 IU | AM | BCMO1 AT — impaired beta-carotene conversion |
| IQ+ Stick (Alpha-GPC) | 300mg active | AM | PEMT TT — genetically required choline supplementation |
| Quercetin | Standard | AM | Anti-inflammatory |
| Vitamin C / D3 / Zinc | C 1g, D3 50mcg, Zn 30mg total | PM | VDR variant — higher D3 need |
| Curcumin Phytosome | 1g | PM | IL-6 GG + 6-variant inflammation cluster |
| Ubiquinol (CoQ10)↗ | 100mg (considering 300-400mg) | PM | SOD2 GG — mitochondrial oxidative stress |
| K2 (MK-7) | 100mcg | PM | CYP4F2 CT — faster K metabolism |
| Omega Max↗ | 3 servings (2,070mg EPA + 780mg DHA) | PM | FADS1/FADS2 het — ~50% reduced conversion; Omega-3 Index was 3.7% |
| Selenium | 200mcg | PM | DIO2 TT — reduced T4→T3 conversion |
| Bio-Fisetin | 1 (switching to pulse 2-3 days/month) | PM | Senolytic |
| Boron↗ | 10mg | PM | T support |
| Stinging Nettle↗ | 375mg (20:1 extract) | PM | SRD5A2 CC — higher DHT activity |
| Spermidine | Standard | PM | Autophagy |
| Lithium Orotate | Standard | PM | Neuroprotection |
| Melatonin | Standard | PM | MTNR1B GG — reduced signaling |
| Magnesium L-Threonate↗ | 144mg (from 2000mg Magtein) | PM | COMT Val/Val cofactor |
| Ashwagandha↗ | 600mg | PM | FKBP5 AA — more reactive HPA axis |
Other Compounds (6)
ACTN3 CC + MTHFR (creatine bypass saves methylation) + GLP-1 lean mass preservation
Mitochondrial + cognitive. MAO-A inhibitor — see gotchas.
ERR agonist, exercise mimetic
NNMT inhibitor — NAD+ + fat loss
HGF/c-Met synaptogenesis, working memory
Triple reuptake inhibitor. Reduced from daily.
Topical Hair Protocol (4)
Anti-androgen at follicle (SRD5A2 CC)
Vasodilator
Hair formula base + boosted Cu
Microneedling synergy
Adderall
Essentially discontinuedPost-Adderall maintenance phase — replaced by Tesofensine + Semax (10u double dose) + Dihexa + GlyNAC + working memory stack.
Pending / Ordered (6)
AChE inhibitor — synergy with Alpha-GPC (PEMT TT)
SUOX AG cofactor — required for NAC 1800mg
CD38 inhibitor — NAD+ bioavailability + adiponectin
Myostatin inhibition for Retatrutide lean mass preservation
Leucine metabolite, anti-atrophy
Multi-pathway muscle preservation